Clinuvel Pharmaceuticals Ltd Cash Flow Reinvestment Rate
Clinuvel Pharmaceuticals Ltd cash flow reinvestment rate. Clinuvel Pharmaceuticals Ltd (CUV) has a Cash Flow Reinvestment Rate of 0.01x as of December 2025, reinvesting AU$149.47K (capex AU$149.47K ) from operating cash flow of AU$12.52 Million. Explore how well can Clinuvel Pharmaceuticals Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Clinuvel Pharmaceuticals Ltd (2017–2025)
Cash flow reinvestment rate of Clinuvel Pharmaceuticals Ltd from 2017 to 2025. Historical reinvestment intensity for Clinuvel Pharmaceuticals Ltd across 9 annual periods. Explore CUV capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Clinuvel Pharmaceuticals Ltd Cash Flow Reinvestment Rate by Year (2017–2025)
Clinuvel Pharmaceuticals Ltd cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for Clinuvel Pharmaceuticals Ltd. For the full cash flow conversion analysis, see CUV operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.17x | AU$48.01 Million | AU$41.10 Million | AU$298.57K | ▲ +25.1% |
| 2024 | 0.93x | AU$34.61 Million | AU$37.05 Million | AU$5.58 Million | ▲ +1577.7% |
| 2023 | 0.06x | AU$2.06 Million | AU$36.91 Million | AU$1.03 Million | ▲ +155.5% |
| 2022 | 0.02x | AU$868.88K | AU$39.87 Million | AU$434.44K | ▼ -75.4% |
| 2021 | 0.09x | AU$1.71 Million | AU$19.26 Million | AU$854.33K | ▼ -29.2% |
| 2020 | 0.13x | AU$1.78 Million | AU$14.19 Million | AU$888.83K | ▲ +348.8% |
| 2019 | 0.03x | AU$515.23K | AU$18.46 Million | AU$257.62K | ▲ +117.3% |
| 2018 | 0.01x | AU$150.25K | AU$11.69 Million | AU$75.12K | ▼ -5.6% |
| 2017 | 0.01x | AU$134.96K | AU$9.92 Million | AU$67.48K | — |